Gene amplification in amphotericin B-resistant Leishmania tarentolae

被引:33
作者
Singh, AK
Papadopoulou, B
Ouellette, M
机构
[1] CHU Laval, Ctr Rech, Ctr Rech Infect, St Foy, PQ G1V 4G2, Canada
[2] Univ Laval, Fac Med, Dept Microbiol, Quebec City, PQ G1V 4G2, Canada
基金
加拿大健康研究院;
关键词
amphotericin B; Leishmania drug resistance; gene amplification;
D O I
10.1006/expr.2001.4663
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Singh, A. K., Papadopoulou, B., and Ouellette, M. 2001. Gene amplification in amphotericin B-resistant Leishmania tarentolae. Experimental Parasitology 99, 141-147. Two Leishmania tarentolae cells were selected step by step for resistance to the polyene antibiotic amphotericin B, a second-line drug against the parasite Leishmania. One of the mutants was cross-resistant to ketoconazole. DNA amplification was observed in both mutants. The amplicons were extrachromosomal circles and were derived from different chromosomes. In one mutant the circle was unusually stable as it remained within the cell despite numerous passages in the absence of the drug. A circumstantial link between the copy number of amplicons and the resistance levels was established. Gene transfection experiments indicated that the link between the locus amplified and the resistance levels was not straightforward and possibly several mutations act together to lead to amphotericin B resistance. (C) 2001 Elsevier Science (USA).
引用
收藏
页码:141 / 147
页数:7
相关论文
共 34 条
[1]  
[Anonymous], 1989, SYNTHETIC OLIGONUCLE
[2]   Human leishmaniasis: Clinical, diagnostic, and chemotherapeutic developments in the last 10 years [J].
Berman, JD .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (04) :684-703
[3]   GENE AMPLIFICATION IN LEISHMANIA [J].
BEVERLEY, SM .
ANNUAL REVIEW OF MICROBIOLOGY, 1991, 45 :417-444
[4]   RECURRENT DENOVO APPEARANCE OF SMALL LINEAR DNAS IN LEISHMANIA-MAJOR AND RELATIONSHIP TO EXTRACHROMOSOMAL DNAS IN OTHER SPECIES [J].
BEVERLEY, SM ;
COBURN, CM .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1990, 42 (01) :133-141
[5]  
BORST P, 1995, ANNU REV MICROBIOL, V49, P427, DOI 10.1146/annurev.mi.49.100195.002235
[6]   Isolation of genes mediating resistance to inhibitors of nucleoside and ergosterol metabolism in Leishmania by overexpression/selection [J].
Cotrim, PC ;
Garrity, LK ;
Beverley, SM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (53) :37723-37730
[7]   Flow cytometric assessment of amphotericin B susceptibility in Leishmania infantum isolates from patients with visceral leishmaniasis [J].
Di Giorgio, C ;
Faraut-Gambarelli, F ;
Imbert, A ;
Minodier, P ;
Gasquet, M ;
Dumon, H .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (01) :71-76
[8]   Leishmania infantum:: Lack of parasite resistance to amphotericin B in a clinically resistant visceral leishmaniasis [J].
Durand, R ;
Paul, M ;
Pratlong, F ;
Rivollet, D ;
Dubreuil-Lemaire, ML ;
Houin, R ;
Astier, A ;
Deniau, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (08) :2141-2143
[9]   In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: A study of 37 strains collected from patients with visceral leishmaniasis [J].
FarautGambarelli, F ;
Piarroux, R ;
Deniau, M ;
Giusiano, B ;
Marty, P ;
Michel, G ;
Faugere, B ;
Dumon, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (04) :827-830
[10]   Antifungal agents: Mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance [J].
Ghannoum, MA ;
Rice, LB .
CLINICAL MICROBIOLOGY REVIEWS, 1999, 12 (04) :501-+